23andMe (ME) Revenue & Revenue Breakdown
23andMe Revenue Highlights
Latest Revenue (Y)
$219.64M
Latest Revenue (Q)
$40.41M
Main Segment (Y)
Consumer Services
Main Geography (Y)
UNITED STATES
23andMe Revenue by Period
23andMe Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $219.64M | -26.66% |
| 2023-03-31 | $299.49M | 10.15% |
| 2022-03-31 | $271.89M | 11.47% |
| 2021-03-31 | $243.92M | -20.15% |
| 2020-03-31 | $305.46M | -30.72% |
| 2019-03-31 | $440.90M | - |
23andMe generated $219.64M in revenue during NA 2023, up -26.66% compared to the previous quarter, and up 49.82% compared to the same period a year ago.
23andMe Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $40.41M | -36.88% |
| 2024-03-31 | $64.03M | 43.09% |
| 2023-12-31 | $44.75M | -10.50% |
| 2023-09-30 | $50.00M | -17.85% |
| 2023-06-30 | $60.86M | -34.11% |
| 2023-03-31 | $92.38M | 38.00% |
| 2022-12-31 | $66.94M | -11.52% |
| 2022-09-30 | $75.66M | 17.28% |
| 2022-06-30 | $64.51M | -35.85% |
| 2022-03-31 | $100.56M | 76.76% |
| 2021-12-31 | $56.89M | 3.06% |
| 2021-09-30 | $55.20M | -6.81% |
| 2021-06-30 | $59.24M | -33.13% |
| 2021-03-31 | $88.58M | 59.67% |
| 2020-12-31 | $55.48M | 7.09% |
| 2020-09-30 | $51.80M | 7.80% |
| 2020-06-30 | $48.06M | - |
23andMe generated $40.41M in revenue during Q1 2024, up -36.88% compared to the previous quarter, and up 43.75% compared to the same period a year ago.
23andMe Revenue Breakdown
23andMe Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|
| Research Services | $27.50M | $67.80M | - |
| PGS | $167.74M | - | - |
| Therapeutics | - | - | - |
| Service | $191.82M | - | - |
| Consumer Services | $202.31M | $247.14M | - |
| Health Care, Other | $34.57M | - | - |
| K I T S | - | $27.70M | - |
23andMe's latest annual revenue breakdown by segment (product or service), as of Mar 24: Consumer Services (32.42%), Service (30.74%), PGS (26.88%), Health Care, Other (5.54%), and Research Services (4.41%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research Services | $19.65M | $1.85M | $2.90M | $3.10M | $31.30M | $43.40M | $59.30M | $17.05M | $34.00M | $39.90M | $50.60M |
| Consumer Services | $88.25M | $42.90M | $48.66M | $22.50M | $10.00M | $24.50M | $83.51M | $46.04M | $44.49M | $47.85M | - |
| Health Care, Other | $17.69M | $7.82M | $9.06M | $11.53M | $7.67M | - | - | - | - | - | - |
| PGS | $93.07M | $35.08M | $39.60M | $71.98M | $38.37M | - | - | - | - | - | - |
| Service | $97.07M | $44.75M | $50.00M | $100.56M | $56.89M | $55.20M | - | - | - | - | - |
| Therapeutics | - | - | - | - | - | - | - | - | - | - | - |
23andMe's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Service (30.74%), PGS (29.48%), Consumer Services (27.95%), Research Services (6.22%), and Health Care, Other (5.60%).
23andMe Revenue Breakdown by Country
Annual Revenue by Country
| Country | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|
| CANADA | $10.56M | $13.58M | $14.29M |
| Other Regions | $4.64M | $5.64M | $6.68M |
| UNITED STATES | $180.15M | $217.24M | $192.44M |
| Research Services | - | - | $67.80M |
23andMe's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (92.22%), CANADA (5.41%), and Other Regions (2.38%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Regions | $1.52M | $1.01M | $1.09M | $1.01M | $1.11M | $1.24M | $1.39M | $2.13M | $1.31M | $1.51M | $1.74M |
| CANADA | $3.46M | $2.38M | $2.56M | $2.17M | $2.87M | $2.84M | $3.04M | $5.24M | $3.06M | $2.75M | $3.24M |
| UNITED STATES | $55.42M | $39.22M | $42.19M | $43.33M | $46.77M | $52.55M | $48.11M | $71.73M | $41.74M | $38.61M | $40.35M |
23andMe's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (91.76%), CANADA (5.72%), and Other Regions (2.52%).
23andMe Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TMO | Thermo Fisher Scientific | $42.86B | $10.54B |
| DHR | Danaher | $14.03B | $3.43B |
| A | Agilent | $6.83B | $1.58B |
| ILMN | Illumina | $4.50B | $1.08B |
| IDXX | IDEXX Laboratories | $3.66B | $1.00B |
| WAT | Waters | $2.96B | $708.53M |
| GH | Guardant Health | $563.95M | $177.24M |
| TWST | Twist Bioscience | $245.11M | $81.46M |
| ME | 23andMe | $219.64M | $40.41M |
| BIOC | Biocept | $25.86M | $589.00K |
| DMTK | DermTech | $15.30M | $3.85M |
| GENE | Genetic | $8.69M | $3.96M |
| HTGM | HTG Molecular Diagnostics | $6.37M | $1.03M |
| SQL | SeqLL | $1.18K | - |
ME Revenue FAQ
What is 23andMe’s yearly revenue?
23andMe's yearly revenue for 2023 was $219.64M, representing a decrease of -26.66% compared to 2022. The company's yearly revenue for 2022 was $299.49M, representing an increase of 10.15% compared to 2021. ME's yearly revenue for 2021 was $271.89M, representing an increase of 11.47% compared to 2020.
What is 23andMe’s quarterly revenue?
23andMe's quarterly revenue for Q1 2024 was $40.41M, a -36.88% decrease from the previous quarter (Q4 2023), and a -33.60% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $64.03M, a 43.09% increase from the previous quarter (Q3 2023), and a -30.69% decrease year-over-year (Q4 2022). ME's quarterly revenue for Q3 2023 was $44.75M, a -10.50% decrease from the previous quarter (Q2 2023), and a -33.15% decrease year-over-year (Q3 2022).
What is 23andMe’s revenue growth rate?
23andMe's revenue growth rate for the last 3 years (2021-2023) was -19.22%, and for the last 5 years (2019-2023) was -28.10%.
What are 23andMe’s revenue streams?
23andMe's revenue streams in r 24 are Research Services, PGS, Service, Consumer Services, and Health Care, Other. Research Services generated $27.5M in revenue, accounting 4.41% of the company's total revenue, down -59.44% year-over-year. PGS generated $167.74M in revenue, accounting 26.88% of the company's total revenue Service generated $191.82M in revenue, accounting 30.74% of the company's total revenue Consumer Services generated $202.31M in revenue, accounting 32.42% of the company's total revenue, down -18.14% year-over-year. Health Care, Other generated $34.57M in revenue, accounting 5.54% of the company's total revenue
What is 23andMe’s main source of revenue?
For the fiscal year ending Mar 24, the largest source of revenue of 23andMe was Consumer Services. This segment made a revenue of $202.31M, representing 32.42% of the company's total revenue.